This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The submission for permanent COVID-19 safety standards comes after temporary pandemic requirements for medical facilities were withdrawn last December.
Amid the ongoing COVID-19 pandemic, this same approach could be taken in relation to masking. A recent study compared COVID-19 spread in Boston-area school districts that dropped mask mandates earlier this year (the majority), with the two much less-resourced school districts that maintained mandates.
Has the worldwide distribution of COVID-19 vaccines been impacted by patent rights? It assumes that once you waive all the COVID patents, everyone all of the sudden starts getting vaccinated quicker and safer, but that’s just not the case. What other IP protections do COVID vaccine manufacturers use? What is a patent?
A research letter published this week in the Journal of the American Medical Association Network Open found that physicians saw a "small but sustained" increase in patient message volume during the first 15 months of the COVID-19 pandemic. At the same time, the message increase did not displace patient calls. ON THE RECORD.
National Nurses United argued before a federal appeals court on Monday that an existing temporary emergency standard isn't enough to protect healthcare workers from the ongoing threat of COVID-19.
Drug Enforcement Agency and Health and Human Services announced the Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, preventing some patients from losing access to their telehealth-prescribed medications.
In June 2022, after almost two years of debate over a potential COVID-19 vaccine patent waiver, the World Trade Organization adopted the Ministerial Decision on the TRIPS Agreement (“WTO Decision”), which provided for a partial waiver of intellectual property rights. The post What Happened to the COVID-19 Vaccine Patent Waiver?
The FDA is planning to give holders of EUAs for COVID-19 diagnostics and other devices 180 days notice of its intent to end their authorizations, in anticipation of U.S. public health emergency declarations stopping.
Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. government committed more than one billion dollars to Moderna for development of its COVID-19 vaccines. By Aparajita Lath.
Physician burnout has risen during the most recent phase of the pandemic, resulting in exacerbated retention challenges among healthcare workers, an MGMA survey and other recent reports have found.
Overall, building a patient management program – most notably in the wake of COVID-19 – is critical. However, adding more technology to fix the woes of other technology often can require many additional resources and can become overwhelming.
The vaccines also reduced infections and hospitalizations, which freed up hospital resources, researchers at the Commonwealth Fund and Yale School of Public Health concluded.
Telehealth use has remained steady this year and did not change nationally from August to September, accounting for 5.4% of all medical claims, according to Fair Health.
The move ends a turbulent saga for AstraZeneca, which successfully developed a coronavirus shot but struggled to sell it amid competition and the emergence of rare but serious side effects.
Hospitals are increasingly acting as venture capitalists, ratcheting up investments in companies with products they can use and scale, according to a data analysis of hospital VC arms conducted by Healthcare Dive.
Telehealth use rose in every census region in November as patients again avoided medical settings and some became infected with the newest coronavirus variant, according to data from Fair Health.
On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. As a result, it publicly promised that “ while the pandemic continues, Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic.”
The agency said on Wednesday that it needs additional time to parse through the 38,000 public comments it received in response to a proposal to reintroduce stricter limits around telehealth prescribing.
seeks to put the COVID-19 pandemic in the rearview mirror, many who survive the initial illness suffer debilitating long-term health impacts, especially those with underlying health conditions. The COVID-19 Research Database features a wide array of data about most of the U.S. Even as the U.S.
In the control group, which received only brief information about the COVID-19 vaccination, there were no comparable results in terms of general views and willingness to vaccinate. per cent), very few people have received the double COVID-19 vaccine dose. THE LARGER TREND. per cent), Ireland (76.2 In Slovakia (45.7
Many people who are currently enrolled in Medicaid will transition to other coverage, but 3.8 million people will completely lose insurance, according to the Robert Wood Johnson Foundation.
Vaccinating as many people as possible to reduce the spread of respiratory illness that can be especially life-threatening for the youngest and oldest Americans is key, argues vaccine law professor Richard Hughes IV.
Cybersecurity has always been chronically underfunded in hospitals, even before COVID-19 swallowed up more resources. Now, this major international threat is creating a "perfect storm," one cybersecurity expert said.
Bankruptcies have spiked this year as federal COVID-19 funding lapsed and heightened interest rates, regulatory changes and labor shortages squeezed the sector.
The COVID-19 pandemic and population growth have led many states to scale back or eliminate Certificate of Need laws, which require providers to get regulatory approval before expanding or adding healthcare facilities.
Although telehealth use declined overall compared to the start of the COVID-19 pandemic, virtual visits still comprised the highest percentage of medical claim lines in 2021.
Patients in communities across the nation who have come to rely on telehealth have been left waiting and wondering if they will be able to receive the virtual care they need once the COVID-19 public health emergency has ended.
The HHS Office of Inspector General found that by loosening emergency use authorization requirements to bring COVID-19 tests to market faster, the agency allowed inaccurate tests to be distributed.
An analysis by KFF found state spending on Medicaid fell during the COVID-19 pandemic even as enrollment soared. But spending will likely increase as the federal government begins to pare back its increased contribution.
HCA and Tenet had operating margins of at least 10% and at least 5%, respectively, in nine out of 11 quarters, according to a report out Monday from the Kaiser Family Foundation.
THE LARGER TREND Congress and telehealth industry groups have urged the DEA and HHS to jointly extend prescribing flexibilities allowed under the original COVID-19 public health emergency since it was initially set to expire.
The new partnership may be a bid to rejuvenate Amwell's hospital revenue, which saw tepid growth last year as major health systems have delayed new hardware deployments during COVID-19.
The unwinding of the COVID-19 public health emergency and recent legislation are expected to influence health spending across the country’s major payers over the next decade.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content